Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 10/2023

29-06-2023 | Ovarian Cancer | Review

Gynecologic oncology tumor board: the central role of the radiologist

Authors: Hannah S. Recht, Kimberly L. Shampain, Marta N. Flory, Stephanie Nougaret, Emma L. Barber, Priyanka Jha, Katherine E. Maturen, Elizabeth A. Sadowski, Atul B. Shinagare, Aradhana M. Venkatesan, Jeanne M. Horowitz

Published in: Abdominal Radiology | Issue 10/2023

Login to get access

Abstract

This manuscript is a collaborative, multi-institutional effort by members of the Society of Abdominal Radiology Uterine and Ovarian Cancer Disease Focus Panel and the European Society of Urogenital Radiology Women Pelvic Imaging working group. The manuscript reviews the key role radiologists play at tumor board and highlights key imaging findings that guide management decisions in patients with the most common gynecologic malignancies including ovarian cancer, cervical cancer, and endometrial cancer.
Literature
1.
El Saghir NS, Keating NL, Carlson RW, Khoury KE, Fallowfield L (2014) Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide. Am Soc Clin Oncol Educ Book:e461-466.
2.
Cohen P, Tan AL, Penman A (2009) The multidisciplinary tumor conference in gynecologic oncology--does it alter management? Int J Gynecol Cancer 19:1470-1472.PubMedCrossRef
3.
Zimlichman E, Nicklin W, Aggarwal R, Bates DW (2021) Health Care 2030: The Coming Transformation. NEJM Catalyst Innovations in Care Delivery
4.
5.
Reinhold C, Rockall A, Sadowski EA, Siegelman ES, Maturen KE, Vargas HA, Forstner R, Glanc P, Andreotti RF, Thomassin-Naggara I (2021) Ovarian-Adnexal Reporting Lexicon for MRI: A White Paper of the ACR Ovarian-Adnexal Reporting and Data Systems MRI Committee. J Am Coll Radiol 18:713-729.PubMedCrossRef
6.
Sadowski EA, Thomassin-Naggara I, Rockall A, Maturen KE, Forstner R, Jha P, Nougaret S, Siegelman ES, Reinhold C (2022) O-RADS MRI Risk Stratification System: Guide for Assessing Adnexal Lesions from the ACR O-RADS Committee. Radiology 303:35-47.PubMedCrossRef
7.
Zhang Q, Dai X, Li W (2023) Systematic Review and Meta-Analysis of O-RADS Ultrasound and O-RADS MRI for Risk Assessment of Ovarian and Adnexal Lesions. AJR Am J Roentgenol:1-13.
8.
Jeong YY, Outwater EK, Kang HK (2000) Imaging evaluation of ovarian masses. Radiographics 20:1445-1470.PubMedCrossRef
9.
Bharwani N, Reznek RH, Rockall AG (2011) Ovarian Cancer Management: the role of imaging and diagnostic challenges. Eur J Radiol 78:41-51.PubMedCrossRef
10.
Vanderpuye VD, Clemenceau JRV, Temin S, Aziz Z, Burke WM, Cevallos NL, Chuang LT, Colgan TJ, Del Carmen MG, Fujiwara K, Kohn EC, Gonzales Nogales JE, Konney TO, Mukhopadhyay A, Paudel BD, Toth I, Wilailak S, Ghebre RG (2021) Assessment of Adult Women With Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified Guideline. JCO Glob Oncol 7:1032-1066.PubMedCrossRef
11.
Iyer VR, Lee SI (2010) MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization. AJR Am J Roentgenol 194:311-321.PubMedCrossRef
12.
Vergote I, Denys H, De Greve J, Gennigens C, Van De Vijver K, Kerger J, Vuylsteke P, Baurain JF (2020) Treatment algorithm in patients with ovarian cancer. Facts Views Vis Obgyn 12:227-239.PubMedPubMedCentral
13.
Avesani G, Arshad M, Lu H, Fotopoulou C, Cannone F, Melotti R, Aboagye E, Rockall A (2020) Radiological assessment of Peritoneal Cancer Index on preoperative CT in ovarian cancer is related to surgical outcome and survival. Radiol Med 125:770-776.PubMedCrossRef
14.
Mazzei MA, Khader L, Cirigliano A, Cioffi Squitieri N, Guerrini S, Forzoni B, Marrelli D, Roviello F, Mazzei FG, Volterrani L (2013) Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Abdom Imaging 38:1422-1430.PubMedCrossRef
15.
Alyami M, Hubner M, Grass F, Bakrin N, Villeneuve L, Laplace N, Passot G, Glehen O, Kepenekian V (2019) Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications. Lancet Oncol 20:e368-e377.PubMedCrossRef
16.
Kang SK, Reinhold C, Atri M, Benson CB, Bhosale PR, Jhingran A, Lakhman Y, al. E ACR Appropriateness Criteria® Staging and Follow-up of Ovarian Cancer American College of Radiology.
17.
Castellani F, Nganga EC, Dumas L, Banerjee S, Rockall AG (2019) Imaging in the pre-operative staging of ovarian cancer. Abdom Radiol (NY) 44:685-696.PubMedCrossRef
18.
Darras KE, Clark SJ, Kang H, Mohammed MF, Barrett S, Chang SD, Harris AC, Nicolaou S, McLaughlin PD (2019) Virtual monoenergetic reconstruction of contrast-enhanced CT scans of the abdomen and pelvis at 40 keV improves the detection of peritoneal metastatic deposits. Abdom Radiol (NY) 44:422-428.PubMedCrossRef
19.
Schmidt S, Meuli RA, Achtari C, Prior JO (2015) Peritoneal carcinomatosis in primary ovarian cancer staging: comparison between MDCT, MRI, and 18F-FDG PET/CT. Clin Nucl Med 40:371-377.PubMedCrossRef
20.
21.
Sahdev A (2016) CT in ovarian cancer staging: how to review and report with emphasis on abdominal and pelvic disease for surgical planning. Cancer Imaging 16:19.PubMedPubMedCentralCrossRef
22.
Qayyum A, Coakley FV, Westphalen AC, Hricak H, Okuno WT, Powell B (2005) Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Gynecol Oncol 96:301-306.PubMedCrossRef
23.
Nougaret S, Addley HC, Colombo PE, Fujii S, Al Sharif SS, Tirumani SH, Jardon K, Sala E, Reinhold C (2012) Ovarian carcinomatosis: how the radiologist can help plan the surgical approach. Radiographics 32:1775-1800; discussion 1800-1773.
24.
Herzog TJ (2004) Recurrent ovarian cancer: how important is it to treat to disease progression? Clin Cancer Res 10:7439-7449.PubMedCrossRef
25.
Manganaro L, Gigli S, Antonelli A, Saldari M, Tomao F, Marchetti C, Anastasi E, Laghi A (2019) Imaging strategy in recurrent ovarian cancer: a practical review. Abdom Radiol (NY) 44:1091-1102.PubMedCrossRef
26.
Testa AC, Di Legge A, Virgilio B, Bonatti M, Manfredi R, Mirk P, Rufini V (2014) Which imaging technique should we use in the follow up of gynaecological cancer? Best Pract Res Clin Obstet Gynaecol 28:769-791.PubMedCrossRef
27.
Gu P, Pan LL, Wu SQ, Sun L, Huang G (2009) CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis. Eur J Radiol 71:164-174.PubMedCrossRef
28.
Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R (2018) Cancer of the cervix uteri. Int J Gynaecol Obstet 143 Suppl 2:22-36.PubMedCrossRef
29.
Balcacer P, Shergill A, Litkouhi B (2019) MRI of cervical cancer with a surgical perspective: staging, prognostic implications and pitfalls. Abdom Radiol (NY) 44:2557-2571.PubMedCrossRef
30.
Salib MY, Russell JHB, Stewart VR, Sudderuddin SA, Barwick TD, Rockall AG, Bharwani N (2020) 2018 FIGO Staging Classification for Cervical Cancer: Added Benefits of Imaging. Radiographics 40:1807-1822.PubMedCrossRef
31.
Dhanda S, Thakur M, Kerkar R, Jagmohan P (2014) Diffusion-weighted imaging of gynecologic tumors: diagnostic pearls and potential pitfalls. Radiographics 34:1393-1416.PubMedCrossRef
32.
Cervical Cancer (Version 1.2022). National Comprehensive Cancer Network.
33.
Rockall AG, Qureshi M, Papadopoulou I, Saso S, Butterfield N, Thomassin-Naggara I, Farthing A, Smith JR, Bharwani N (2016) Role of Imaging in Fertility-sparing Treatment of Gynecologic Malignancies. Radiographics 36:2214-2233.PubMedCrossRef
34.
Patel-Lippmann K, Robbins JB, Barroilhet L, Anderson B, Sadowski EA, Boyum J (2017) MR Imaging of Cervical Cancer. Magn Reson Imaging Clin N Am 25:635-649.PubMedCrossRef
35.
Manganaro L, Lakhman Y, Bharwani N, Gui B, Gigli S, Vinci V, Rizzo S, Kido A, Cunha TM, Sala E, Rockall A, Forstner R, Nougaret S (2021) Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018. Eur Radiol 31:7802-7816.PubMedCrossRef
36.
Otero-Garcia MM, Mesa-Alvarez A, Nikolic O, Blanco-Lobato P, Basta-Nikolic M, de Llano-Ortega RM, Paredes-Velazquez L, Nikolic N, Szewczyk-Bieda M (2019) Role of MRI in staging and follow-up of endometrial and cervical cancer: pitfalls and mimickers. Insights Imaging 10:19.PubMedPubMedCentralCrossRef
37.
Patel K, Foster NR, Kumar A, Grudem M, Longenbach S, Bakkum-Gamez J, Haddock M, Dowdy S, Jatoi A (2015) Hydronephrosis in patients with cervical cancer: an assessment of morbidity and survival. Support Care Cancer 23:1303-1309.PubMedCrossRef
38.
Saleh M, Virarkar M, Javadi S, Elsherif SB, de Castro Faria S, Bhosale P (2020) Cervical Cancer: 2018 Revised International Federation of Gynecology and Obstetrics Staging System and the Role of Imaging. AJR Am J Roentgenol 214:1182-1195.PubMedCrossRef
39.
Gee MS, Atri M, Bandos AI, Mannel RS, Gold MA, Lee SI (2018) Identification of Distant Metastatic Disease in Uterine Cervical and Endometrial Cancers with FDG PET/CT: Analysis from the ACRIN 6671/GOG 0233 Multicenter Trial. Radiology 287:176-184.PubMedCrossRef
40.
Friedlander M, Grogan M, Force USPST (2002) Guidelines for the treatment of recurrent and metastatic cervical cancer. Oncologist 7:342-347.PubMedCrossRef
41.
42.
Schmidt AM, Imesch P, Fink D, Egger H (2012) Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer. Gynecol Oncol 125:604-609.PubMedCrossRef
43.
44.
Constantine GD, Kessler G, Graham S, Goldstein SR (2019) Increased Incidence of Endometrial Cancer Following the Women's Health Initiative: An Assessment of Risk Factors. J Womens Health (Larchmt) 28:237-243.PubMedCrossRef
45.
Lewin SN, Herzog TJ, Barrena Medel NI, Deutsch I, Burke WM, Sun X, Wright JD (2010) Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer. Obstet Gynecol 116:1141-1149.PubMedCrossRef
46.
Beddy P, O'Neill AC, Yamamoto AK, Addley HC, Reinhold C, Sala E (2012) FIGO staging system for endometrial cancer: added benefits of MR imaging. Radiographics 32:241-254.PubMedCrossRef
47.
Amant F, Mirza MR, Koskas M, Creutzberg CL (2018) Cancer of the corpus uteri. Int J Gynaecol Obstet 143 Suppl 2:37-50.PubMedCrossRef
48.
Nougaret S, Horta M, Sala E, Lakhman Y, Thomassin-Naggara I, Kido A, Masselli G, Bharwani N, Sadowski E, Ertmer A, Otero-Garcia M, Kubik-Huch RA, Cunha TM, Rockall A, Forstner R (2019) Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology. Eur Radiol 29:792-805.PubMedCrossRef
49.
50.
51.
Jobo T, Sato R, Arai T, Tamura T, Watanabe J, Kuramoto H (2005) Lymph node pathway in the spread of endometrial carcinoma. Eur J Gynaecol Oncol 26:167-169.PubMed
52.
53.
Metadata
Title
Gynecologic oncology tumor board: the central role of the radiologist
Authors
Hannah S. Recht
Kimberly L. Shampain
Marta N. Flory
Stephanie Nougaret
Emma L. Barber
Priyanka Jha
Katherine E. Maturen
Elizabeth A. Sadowski
Atul B. Shinagare
Aradhana M. Venkatesan
Jeanne M. Horowitz
Publication date
29-06-2023

Other articles of this Issue 10/2023

Abdominal Radiology 10/2023 Go to the issue

Classics in Abdominal Radiology

The split-wall sign

Pancreas

Diagnosis of chronic pancreatitis using semi-quantitative MRI features of the pancreatic parenchyma: results from the multi-institutional MINIMAP study

Review

Percutaneous cholecystostomy: techniques and applications

Kidneys, Ureters, Bladder, Retroperitoneum

Deep learning approach for differentiating indeterminate adrenal masses using CT imaging

Hollow Organ GI

Predicting response to chemoradiotherapy in rectal cancer via visual morphologic assessment and staging on baseline MRI: a multicenter and multireader study

Hollow Organ GI

Stercoral colitis: CT imaging findings and clinical risk factors
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits